Coeptis Therapeutics HoldingsCOEP +1.52%12 Market Cap is $102.06 Mil as of Jun. 27, 2026. GuruFocus rates COEP with a GF Score™ of 12/100. Among 1,431 Biotechnology companies, Coeptis Therapeutics Holdings ranks worse than 51.85% on this metric.
Coeptis Therapeutics Holdings's quarterly market cap
increased
from Jun. 2025 ($32.50 Mil) to Sep. 2025 ($90.06 Mil) but then
declined
from Sep. 2025 ($90.06 Mil) to Dec. 2025 ($81.89 Mil).
Coeptis Therapeutics Holdings's annual market cap
declined
from Dec. 2023 ($27.70 Mil) to Dec. 2024 ($11.64 Mil) but then
increased
from Dec. 2024 ($11.64 Mil) to Dec. 2025 ($81.89 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Coeptis Therapeutics Holdings's Enterprise Value for Today is $96.49 Mil.
Coeptis Therapeutics Holdings (NAS:COEP) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Coeptis Therapeutics Holdings Market Cap Related Terms
Coeptis Therapeutics Holdings Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Coeptis Therapeutics Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Coeptis Therapeutics Holdings Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Coeptis Therapeutics Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Coeptis Therapeutics Holdings's Market Cap falls into.
Coeptis Therapeutics Holdings Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Coeptis Therapeutics Holdings (COEP) has a Market Cap of $102.06 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Coeptis Therapeutics Holdings and its competitors. According to the industry distribution chart, Coeptis Therapeutics Holdings ranks #742 out of 1431 companies in the Biotechnology industry, placing it in the top 51.9%.
Is Coeptis Therapeutics Holdings' Market Cap too high?
Coeptis Therapeutics Holdings' current Market Cap is $102.06 Mil. The Biotechnology industry median Market Cap is 113.83. Coeptis Therapeutics Holdings' value of $102.06 Mil is 10.3% below this industry median. Based on the distribution chart, Coeptis Therapeutics Holdings ranks #742 out of 1431 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Coeptis Therapeutics Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Coeptis Therapeutics Holdings' Market Cap compare to ANIX and COYA?
According to the Biotechnology industry distribution chart, Coeptis Therapeutics Holdings ranks #742 out of 1431 companies for Market Cap. This places Coeptis Therapeutics Holdings in the lower half of its industry. The industry median Market Cap is 113.83. Coeptis Therapeutics Holdings' value of $102.06 Mil is 10.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 113.83, based on 1,431 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Coeptis Therapeutics Holdings's current Market Cap of $102.06 Mil is 10.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Coeptis Therapeutics Holdings and its competitors. For the Biotechnology industry, the median Market Cap is 113.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Coeptis Therapeutics Holdings's current Market Cap is $102.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coeptis Therapeutics Holdings stock overvalued right now?
Coeptis Therapeutics Holdings (COEP) has a current Market Cap of $102.06 Mil. The current Market Cap is $102.06 Mil and 10.3% below the Biotechnology industry median of 113.83. Coeptis Therapeutics Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Coeptis Therapeutics Holdings (COEP), the current Market Cap is $102.06 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Coeptis Therapeutics Holdings Business Description
Coeptis Therapeutics Holdings Inc is a biopharmaceutical and technology company. The biopharmaceutical division focuses on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its research and development efforts. The technology division focuses on enhancing operational capabilities through technologies. This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency. It derives the majority of the revenue from the Technology segment.
12GF Score
Get the complete analysis for COEP
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COEP has been successfully added to your 
